December 19, 2019
“What we have tracked and seen in the last four years is a very vibrant ecosystem, which was in the past, very e-commerce health focused to nowadays, very sophisticated with AI drug discovery, clinical trials and digital therapeutics etc. In 2018, the total amount of venture capital that was invested in Asia Pacific amounted to about $6.8B. To put in context, in the US it is $8.2B and $2B for...
Above photo: Dr. Min-Han Tan, founder and CEO of Lucence. Credit: Lucence
November 20, 2019
Singapore-headquartered genomic medicine startup Lucence announced it has raised $20 million in Series A funding. The round was led by IHH Healthcare, one of the world’s largest integrated private healthcare groups, with 80 hospitals in 10 countries worldwide. Other participants include SGInnovate, existing investors Heliconia Capital, a subsidiary of Temasek Holdings, Lim Kaling and Koh Boon...